Physician profile
Kevin Chiappone
NPI 1144645466
$2,008.65
in general payments reported to CMS, 2019-2025
24 companies · $455 in 2025
The $455 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $179 · 2022: $160 · 2023: $228 · 2024: $987 · 2025: $455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,653 · Gift: $16.65.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,653.47 |
| Gift | $16.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $339.70 | 2021-2025 | |
| Tolmar, INC. | $237.17 | 2023-2025 | Eligard, Jatenzo |
| Sumitomo Pharma America, INC. | $236.41 | 2024-2025 | Gemtesa, Orgovyx |
| Astellas Pharma US INC | $147.89 | 2021-2024 | Myrbetriq |
| Urogen Pharma, INC. | $122.78 | 2024-2025 | |
| Boston Scientific Corporation | $117.06 | 2021-2025 | Rezum Generator, Axonics |
| Merck Sharp & Dohme LLC | $106.26 | 2023-2024 | Keytruda, Welireg, Lynparza |
| Bayer Healthcare Pharmaceuticals INC. | $99.81 | 2024 | |
| Accord Healthcare, INC. | $89.32 | 2023-2024 | |
| Laborie Medical Technologies Corp. | $69.73 | 2021-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Myriad Genetic Laboratories, INC. | $61.50 | 2021-2023 | Prolaris |
| Lazarus 3d | $56.74 | 2022 | |
| Convatec INC. | $54.99 | 2025 | |
| Angiodynamics, INC. | $42.11 | 2024 | Nanoknife |
| Pfizer INC. | $40.28 | 2024 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $28.48 | 2023 | Pylarify |
| Vertex Pharmaceuticals Incorporated | $26.95 | 2025 | |
| Procept Biorobotics Corporation | $25.14 | 2025 | |
| Ambu INC. | $24.10 | 2025 | |
| Baxter Healthcare | $21.66 | 2025 | Tisseel |
| Novartis Pharmaceuticals Corporation | $19.54 | 2024 | |
| Verity Pharmaceuticals INC. | $14.52 | 2024 | Trelstar |
| Axonics, INC. | $13.67 | 2023 | Axonics, Bulkamid |
| Karl Storz Endoscopy-America | $12.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Chiappone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.